Cargando…
Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy
BACKGROUND: Bleeding is the most common complication of oral anticoagulants, due to inadequate dosing. CASE PRESENTATION: This report describes the clinical course of a patient who developed severe bleeding under therapy with phenprocoumon, despite an INR in the lower therapeutic range. Strikingly,...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243751/ https://www.ncbi.nlm.nih.gov/pubmed/34187575 http://dx.doi.org/10.1186/s40001-021-00533-7 |